{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:24:20Z","timestamp":1762867460195},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10157-018-1574-2","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T15:15:25Z","timestamp":1527002125000},"page":"1213-1223","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan"],"prefix":"10.1007","volume":"22","author":[{"given":"Tsuyoshi","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatsugu","family":"Okegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuo","family":"Nutahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1574_CR1","first-page":"511","volume":"53","author":"J Milutinovic","year":"1984","unstructured":"Milutinovic J, Fialkow PJ, Agodoa LY, et al. Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med. 1984;53:511\u201322.","journal-title":"Q J Med."},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/ki.1984.154","volume":"26","author":"DN Churchill","year":"1984","unstructured":"Churchill DN, Bear JC, Morgan J, et al. Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int. 1984;26:190\u20133.","journal-title":"Kidney Int"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41:1311\u20139.","journal-title":"Kidney Int"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000045214","volume":"80","author":"E Higashihara","year":"1998","unstructured":"Higashihara E, Nutahara K, Kojima M, et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron. 1998;80:421\u20137.","journal-title":"Nephron"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1046\/j.1523-1755.2000.00014.x","volume":"57","author":"JD Kopple","year":"2000","unstructured":"Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688\u2013703.","journal-title":"Kidney Int"},{"key":"1574_CR6","first-page":"126","volume":"21","author":"JE Carlsen","year":"1980","unstructured":"Carlsen JE, M\u00f8ller ML, Lund JO, et al. Comparison of four commercial Tc-99m(Sn)DTPA preparations used for the measurement of glomerular filtration rate: concise communication. J Nucl Med. 1980;21:126\u20139.","journal-title":"J Nucl Med"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(67)92781-X","volume":"15","author":"ES Garnett","year":"1967","unstructured":"Garnett ES, Parsons V, Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet. 1967;15:818\u20139.","journal-title":"Lancet"},{"key":"1574_CR8","first-page":"155","volume":"59","author":"M Yanai","year":"2013","unstructured":"Yanai M. Measurement of glomerular filtration rate and its estimation equation. Mod Media. 2013;59:155\u201360.","journal-title":"Mod Media"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10157-008-0084-z","volume":"13","author":"M Horio","year":"2009","unstructured":"Horio M, Imai E, Yasuda Y, et al. Japanese equation for estimating GFR: Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol. 2009;13:50\u20134.","journal-title":"Clin Exp Nephrol"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000256657","volume":"31","author":"B Orskov","year":"2010","unstructured":"Orskov B, Borresen ML, Feldt-Rasmussen B, et al. Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease. Am J Nephrol. 2010;31:53\u20137.","journal-title":"Am J Nephrol"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","volume":"40","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221\u20136.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s10157-011-0525-y","volume":"15","author":"M Horio","year":"2011","unstructured":"Horio M, Imai E, Yasuda Y, et al. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol. 2011;15:868 \u2013 76.","journal-title":"Clin Exp Nephrol"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652\u201360.","journal-title":"Kidney Int"},{"key":"1574_CR14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, et al. TEMPO 3:4 trial investigators: tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407\u201318.","journal-title":"N Engl J Med"},{"key":"1574_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10157-015-1086-2","volume":"19","author":"S Muto","year":"2015","unstructured":"Muto S, Kawano H, Higashihara E, et al. The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clin Exp Nephrol. 2015;19:867\u201377.","journal-title":"Clin Exp Nephrol"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10157-015-1134-y","volume":"20","author":"T Kawada","year":"2016","unstructured":"Kawada T. The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2016;20:147\u201348.","journal-title":"Clin Exp Nephrol"},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","volume":"156","author":"A Earley","year":"2012","unstructured":"Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration Rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012;156:785\u201395.","journal-title":"Ann Intern Med"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, Paterson AD, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20:205\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR20","unstructured":"http:\/\/www.kidney.org\/professionals\/kdoqi\/guidelines_ckd\/p4_class_gl.htm.2009\n                    \n                  . Retrieved on Sept 2015."},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10157-013-0834-4","volume":"18","author":"E Higashihara","year":"2014","unstructured":"Higashihara E, Nutahara K, Okegawa T, et al. Kidney volume and function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2014;18:157\u201365.","journal-title":"Clin Exp Nephrol"},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"1574_CR23","first-page":"155A","volume":"11","author":"AS Levey","year":"2000","unstructured":"Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, et al. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 2010;56:32\u20138.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, CKD-EPI Investigators, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139.","journal-title":"N Engl J Med"},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","volume":"61","author":"M Horio","year":"2013","unstructured":"Horio M, Imai E, Yasuda Y, et al. Collaborators developing the Japanese equation for estimated GFR: GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197\u2013203.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877\u201384.","journal-title":"N Engl J Med"},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473\u201383.","journal-title":"N Engl J Med"},{"key":"1574_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.ajkd.2016.10.021","volume":"69","author":"C Shen","year":"2017","unstructured":"Shen C, Landsittel D, Irazabal MV, et al. CRISP Investigators: Performance of the CKD-EPI equation to estimate GFR in a longitudinal study of autosomal dominant polycystic kidney disease. Am J Kidney Dis 2017;69:482\u20134.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02295996","volume":"12","author":"Q McNemar","year":"1947","unstructured":"McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12:153\u20137.","journal-title":"Psychometrika"},{"key":"1574_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2215\/CJN.06870909","volume":"5","author":"WM Michels","year":"2010","unstructured":"Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft\u2013Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J am Soc Nephrol. 2010;5:1003\u20139.","journal-title":"Clin J am Soc Nephrol"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/ajprenal.00507.2009","volume":"299","author":"C Donadio","year":"2010","unstructured":"Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary \u03b2-trace protein. Am J Physiol Renal Physiol. 2010;299:407\u201323.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.ajkd.2013.03.030","volume":"62","author":"EM Spithoven","year":"2013","unstructured":"Spithoven EM, Meijer E, Boertien WE, et al. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations. Am J Kid Dis. 2013;62:531\u201340.","journal-title":"Am J Kid Dis"},{"key":"1574_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, et al. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int. 2003;64:1035\u201345.","journal-title":"Kidney Int"},{"key":"1574_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0009-8981(00)00298-9","volume":"300","author":"N Cimerman","year":"2000","unstructured":"Cimerman N, Brguljan PM, Krasovec M, et al. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300:83\u201395.","journal-title":"Clin Chim Acta"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/00365519509110261","volume":"55","author":"M Bjarnad\u00f3ttir","year":"1995","unstructured":"Bjarnad\u00f3ttir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest. 1995;55:617\u201323.","journal-title":"Scand J Clin Lab Invest"},{"key":"1574_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/ajkd.1998.v32.pm9669420","volume":"32","author":"M Walser","year":"1998","unstructured":"Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998;32:23\u201331.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000057599","volume":"91","author":"JJ Kazama","year":"2002","unstructured":"Kazama JJ, Kutsuwada K, Ataka K, et al. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron. 2002;91:13\u201320.","journal-title":"Nephron"},{"key":"1574_CR42","doi-asserted-by":"publisher","first-page":"e0174583","DOI":"10.1371\/journal.pone.0174583","volume":"12","author":"L Sans","year":"2017","unstructured":"Sans L, Radosevic A, Quintian C, et al. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease. PLOS One. 2017;12:e0174583.","journal-title":"PLOS One"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1574-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T16:49:30Z","timestamp":1558543770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1574-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which this studies were conducted and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics Committee approval has been obtained (Approval number 482).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}